Covid-19 vaccines achieved the goals of protecting vulnerable people and easing pressures on healthcare, says the head of Switzerland’s Federal Vaccination Commission.
This content was published on
2 minutes
swissinfo.ch/mga
Español
es
Expertos confirman éxito de vacunas COVID, pese a efectos secundarios
But Christoph Berger also acknowledged that further research is needed to determine the severity and causes of various vaccine side-effects to people’s health.
Around 70% of the Swiss population have had at least one dose of a vaccine against Covid-19. A minority of people have reported adverse symptoms, from headaches and fatigue to inflammation of heart muscles.
“It is clear that there are undesirable vaccination symptoms, including severe ones. We must take these people and their suffering seriously and help them too,” Berger told the Tamedia media group on Monday.
“There is as yet no clear diagnosis of this post-vac syndrome. The term is a collective pot for various symptoms that could at least have a temporal connection with the vaccination. Maybe the connection is causal or not.”
Berger said more research is needed to get to the bottom of side-effects but gave the vaccination campaign an over-all positive assessment.
“It is clear that vaccination benefits far outweigh the risks. We never assumed that we would make the virus go away. Our goal has always been to prevent as many serious cases as possible through vaccination so that the healthcare system is not overburdened,” he said.
The government has urged people to get booster shots this winter, especially the elderly and those with underlying health conditions.
Switzerland currently has administered nearly 17 million vaccine doses and still has a stockpile of around 13.5 million doses, with millions more on order.
According not the latest figures, a total of 1,260 new lab-confirmed Covid cases were reported in Switzerland January 17 over the previous seven-days.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
This content was published on
Covid-19 shots will remain free in Switzerland in 2023, including for residents and cross-border workers not subject to compulsory health insurance.
Covid-19 booster shots available to Swiss residents
This content was published on
The authorities recommend that people aged over 16, especially the most vulnerable, get a booster shot to contain a new wave of infections.
Can Switzerland convince its people to take the Covid-19 vaccine?
This content was published on
With several vaccines in late stages of development, the next step is to address widespread scepticism so enough people will agree to the jab.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.